Manhattan Associates (MANH) is down 3.66% to $127.37 as the market digests another round of analyst caution focused on 2026 fundamentals. The most recent catalyst in the news flow is a Barclays price-target reduction in mid-March that, despite keeping a positive rating, reinforced concerns that near-term growth and visibility are not improving fast enough to support a higher multiple.

Barclays maintained an Overweight stance but lowered its price target on March 16, 2026, a setup that often reads as “still like it, but don’t pay up yet.” With MANH already sensitive to any perceived deceleration in enterprise software spending and professional services execution, incremental target trims can be enough to push the stock lower on a down tape—especially when investors are quick to de-risk high-quality but valuation-dependent software names. �citeturn2search6
�citeturn2search4

The stock’s reaction reflects lingering skepticism around the company’s 2026 outlook after prior guidance-driven volatility earlier in the year, where softer-than-expected forward expectations outweighed strong quarterly performance. That backdrop increases the impact of any new messaging that implies a slower ramp in services and implementation activity, even when subscription/cloud fundamentals remain intact. �citeturn1search8
�citeturn0search5

Investors will be watching whether more firms follow with estimate resets, and whether management commentary in upcoming events can improve confidence in re-accelerating demand and services execution. Separately, Manhattan Associates’ CFO succession scheduled for March 31, 2026 adds a near-term event marker that can amplify caution and position-adjusting when the stock is already under pressure. �citeturn2search3